Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 2156-2159, October 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strausser, H. R.
Right arrow Articles by Bober, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strausser, H. R.
Right arrow Articles by Bober, L. A.

Inhibition of Tumor Growth and Survival of Aged Mice Inoculated with Moloney Tumor Transplants and Treated with Endotoxin1

Helen R. Strausser2 and Loretta A. Bober

Department of Zoology and Physiology, Rutgers University, Newark, New Jersey 07102

The pattern of tumor growth and mortality has been traced in CF 1/S female mice, ages 15 to 20 months, following inoculation with 3 x 107 Moloney virus-induced sarcoma cells, propagated in 6-month-old CF1/S irradiated hosts. All the aged mice developed large tumors with widespread metastases, and 65% of these mice died before the end of the 60-day experimental period. Most younger mice tested (2 to 9 months old) rejected the tumor transplants and survived the 60 days. Administration of Salmonella enteritidis endotoxin i.m., in amounts greater than 0.01 µg, 3 times per week for 60 days, starting 24 hr after tumor inoculation, increased the mortality rate with increased numbers of deaths due to tumor growth. Amounts of 0.1 and 1.0 ng endotoxin markedly increased the survival rate as well as the rate of tumor regression. Since endotoxin has been shown to be a repressor of the immune system in high doses and a stimulator in a low doses, it is hypothesized that in aged mice ng amounts of endotoxin enhance immune responsiveness and thereby reduce death from tumors.

1 This work was supported by NIH Biomedical Grant FR 7059 and Rutgers Research Council Grant 2085.

2 Recipient of a Rutgers Research Council Fellowship during part of the tenure of which this work was done.

Received 4/28/72. Accepted 6/19/72.




This article has been cited by other articles:


Home page
J. Bacteriol.Home page
A. M. Chakrabarty
Microorganisms and Cancer: Quest for a Therapy
J. Bacteriol., May 1, 2003; 185(9): 2683 - 2686.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.